Thiazolidinediones Suppress Endothelin-1 Secretion from Bovine Vascular Endothelial Cells: A New Possible Role of PPARγ on Vascular Endothelial Function
- 27 January 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 254 (3) , 757-763
- https://doi.org/10.1006/bbrc.1998.0126
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Troglitazone inhibits angiotensin II‐induced DNA synthesis and migration in vascular smooth muscle cellsFEBS Letters, 1997
- Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia.Journal of Clinical Investigation, 1996
- PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene.The EMBO Journal, 1996
- Effects of Troglitazone: A new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapyDiabetes Care, 1996
- A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiationCell, 1995
- An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)Journal of Biological Chemistry, 1995
- Treatment with the Thiazolidinedione (BRL 49653) Decreases Insulin Resistance in Obese Zucker HindlimbHormone and Metabolic Research, 1995
- Metabolic Effects of Troglitazone on Fructose-Induced Insulin Resistance in the RatDiabetes, 1994
- Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with TroglitazoneNew England Journal of Medicine, 1994
- Troglitazone Prevents Glucose-Induced Insulin Resistance of Insulin Receptor in Rat-1 FibroblastsDiabetes, 1994